The Vanguard Group, Inc. has recently announced that it has increased stake in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) by 0.36%. After grabbing 14.56 million shares, the institutional investor is now in possession of 52828.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.33% having worth around $130.63 million. Moreover, SSgA Funds Management, Inc. increased its share by 0.97 million to have a control over 12.0 million shares. And Renaissance Technologies LLC raised its holdings to 0.48 million shares by acquiring 5.8 million shares or 3.72% of the stake.
Ironwood Pharmaceuticals Inc (IRWD) concluded trading on 12/14/23 at a closing price of $11.45, with 5.07 million shares of worth about $58.1 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.81% during that period and on Thursday the price saw a gain of about 7.11%. Currently the company’s common shares owned by public are about 154.03M shares, out of which, 152.50M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 52 times over the past 12 months. They bought 985,264 shares in 24 of the transactions. In 28 selling transactions, insiders dumped 431,253 shares.
iShares Core S&P Small Cap ETF, SPDR S&P Biotech ETF, and Vanguard Total Stock Market ETF are the top 3 mutual funds which are holding stakes in Ironwood Pharmaceuticals Inc iShares Core S&P Small Cap ETF is currently holding 9.27 million shares of worth totaling $83.13 million. The company recently came selling 1620.0 shares which brought its stake up to 5.94% of the company’s outstanding shares. SPDR S&P Biotech ETF bought 71677.0 shares, after which its hold over company’s outstanding shares expand to 4.87%, leaving 7.6 million shares with the mutual fund that have a worth of about $68.18 million. Vanguard Total Stock Market ETF, after buying 4.15 million shares, have now control over 2.66% of the stake in the company. It holds 18779.0 shares of worth $37.25 million.
However, the stock later moved at a day high price of 12.09, or with a gain of 7.11%. Stock saw a price change of 10.10% in past 5 days and over the past one month there was a price change of 17.44%. Year-to-date (YTD), IRWD shares are showing a performance of -7.59% which decreased to -6.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.07 but also hit the highest price of $12.66 during that period. The average intraday trading volume for Ironwood Pharmaceuticals Inc shares is 2.42 million. The stock is currently trading 14.80% above its 20-day simple moving average (SMA20), while that difference is up 19.23% for SMA50 and it goes to 12.86% higher than SMA200.
The Vanguard Group, Inc. acquired 14.56 million shares of Ironwood Pharmaceuticals Inc having value of about $130.63 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 52828.0 shares in the company valued at close to $604880.6, or have control over 0.36% stake in the company. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) currently have 154.03M outstanding shares and institutions hold larger chunk of about 105.66% of that. Holding of mutual funds in the company is about 51.52% while other institutional holders and individual stake holders have control over 54.46% and 22.29% of the stake respectively.
The stock has a current market capitalization of $1.79B and its 3Y-monthly beta is at 0.74. It has posted earnings per share of -$6.24 in the same period. It has Quick Ratio of 0.90. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IRWD, volatility over the week remained 4.85% while standing at 3.72% over the month.
Analysts are in expectations that Ironwood Pharmaceuticals Inc (IRWD) stock would likely to be making an EPS of $0.21 in the current quarter, while forecast for next quarter EPS is $0.15 and it is $0.82 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.11 which is $0.39 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.27 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -696.25% while it is estimated to increase by 112.89% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on Dec-15-23 offering an Overweight rating for the stock and assigned a target price of $20 to it.
